Overview
ScaleReady is a strategic partnership providing scalable and cost-effective closed workflow solutions for immune cell therapy manufacturing. The platform integrates GMP cytokines, gene engineering capabilities, and G-Rex bioreactors to enable linear process scaling from development to commercial production. ScaleReady addresses manufacturing complexity by automating unit operations, reducing skilled personnel requirements, and supporting addressable patient populations of 30,000+ patients annually.
Frequently asked questions
- What technologies does ScaleReady integrate into its manufacturing platform?
- ScaleReady combines GMP cytokines, gene engineering tools, and G-Rex bioreactors within a closed workflow system designed for intelligent and intentional cell therapy manufacturing.
- How does ScaleReady support process scaling from development to commercial production?
- The platform enables linear scaling, allowing rapid process development at small scale with protocols that predictably scale up and out. This linear model provides transparency for modeling and visibility of scaling requirements needed to meet future patient populations.
- What are the key operational benefits of using ScaleReady's approach?
- ScaleReady reduces process complexity and personnel requirements through automated unit operations and G-Rex bioreactor design, which eliminates unnecessary process interventions while increasing repeatability and cost-effectiveness.